Supernus Pharmaceuticals, Inc.

LOS ANGELES CAPITAL MANAGEMENT LLC SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

7,505

Value ($000)

424

Weight

0.0%

2019 Q4 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	424	0.0%	7,505	12/31/2025
2025 Q3	10/20/2025	918	0.0%	19,214	9/30/2025
2025 Q2	8/7/2025	606	0.0%	19,214	6/30/2025
2025 Q1	5/5/2025	629	0.0%	19,214	3/31/2025
2024 Q4	2/4/2025	694	0.0%	19,183	12/31/2024
2024 Q3	11/4/2024	625	0.0%	20,033	9/30/2024
2023 Q2	8/3/2023	725	0.0%	24,105	6/30/2023
2021 Q2	8/5/2021	699	0.0%	22,690	6/30/2021
2021 Q1	5/5/2021	982	0.0%	37,510	3/31/2021
2020 Q4	3/10/2021	525	0.0%	20,880	12/31/2020
2020 Q2	8/5/2020	260	0.0%	10,956	6/30/2020
2020 Q1	5/4/2020	186	0.0%	10,321	3/31/2020
2019 Q4	2/7/2020	393	0.0%	16,576	12/31/2019